Skip to content
Trial Eligibility
Menu

Type 2 Diabetes Clinical Trials near Orlando, FL

27 studies for Type 2 Diabetes are recruiting at 46 sites within 50 miles of Orlando, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Type 2 Diabetes trials in the US or all trials near Orlando.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Type 2 Diabetes studies enrolling near Orlando

Showing 27 studies, nearest first.
  1. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    NCT07064473

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Florida Institute for Clinical Research (Orlando, FL); Hillcrest Medical Research (DeLand, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

    NCT07282743

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Florida Institute for Clinical Research LLC (Orlando, FL); Alliance for Multispecialty Research (AMR Clinical) - Wichita East (Lakeland, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

    NCT07527650

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Charter Research (Orlando, FL); Accel Research Sites - DeLand (DeLand, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

    NCT07783802

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Florida Institute For Clinical Research, LLC (Orlando, FL); K2 Medical Research - Maitland (Maitland, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. The RESET System Pivotal Clinical Trial (Protocol Revision K)

    NCT04101669

    • Interventional
    • Ages 22 to 65 years
    • Sex: All

    Nearest sites: Orlando Health (Orlando, FL); Optimal Research Sites (Orange City, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

    NCT07271186

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Central Florida Kidney Specialists Oakwater (Orlando, FL); Progressive Medical Research (Port Orange, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

    NCT07684144

    • Phase 3
    • Ages 18 to 99 years
    • Sex: All

    Nearest sites: Florida Institute for Clinical Research (Orlando, FL); Conquest Research - Winter Park (Winter Park, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

    NCT03761446

    • Interventional
    • Ages 60 to 80 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Translational Research Institute for Metabolism and Diabetes (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

    NCT06739122

    • Phase 3
    • Ages 10 to 17 years
    • Sex: All

    Nearest site: AdventHealth Orlando (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

    NCT06993454

    • Interventional
    • Ages 25 to 55 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: AdventHealth Translational Research Institute (Orlando, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

    NCT07296484

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Conquest Research (Winter Park, FL); Velocity Clinical Research, New Smyrna Beach (Edgewater, FL)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  12. A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

    NCT07754461

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Conquest Research (Winter Park, FL); Accel Research Sites - Lakeland (Lakeland, FL)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  13. A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

    NCT07282600

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Clinical Site Partners, LLC dba Flourish Research (Winter Park, FL); Adult Medicine of Lake County, Inc. (Mt. Dora, FL)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

    NCT07340320

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Conquest Research LLC - Winter Park (Winter Park, FL)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

    NCT07502508

    • Phase 2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Flourish Research Orlando (Winter Park, FL)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

    NCT07654374

    • Phase 3
    • Ages 18 to 79 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: ACCOMPLISH-2 Research Site (Ocoee, FL); ACCOMPLISH-2 Research Site (Leesburg, FL)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

    NCT07606066

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Ocoee, FL)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

    NCT07662135

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Ocoee, FL)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

    NCT07664553

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site (Ocoee, FL)

    Distance to nearest recruiting site
    ~10 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

    NCT06897475

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Oviedo Medical Research (Oviedo, FL)

    Distance to nearest recruiting site
    ~14 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

    NCT07282613

    • Phase 3
    • Ages 10 to 18 years
    • Sex: All

    Nearest site: Innovus Clinical (Kissimmee, FL)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

    NCT07817251

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Adult Medicine of Lake County, Inc (Mt. Dora, FL); Optimal Research Sites (Orange City, FL)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  23. HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

    NCT07546929

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Velocity Clinical Research New Smyrna Beach (Edgewater, FL)

    Distance to nearest recruiting site
    ~43 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

    NCT07743450

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: AURORA-2 Clinical Site (The Villages, FL)

    Distance to nearest recruiting site
    ~45 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

    NCT07223333

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Progressive Medical Research (Port Orange, FL)

    Distance to nearest recruiting site
    ~48 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

    NCT07351058

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Progressive Medical Research (Port Orange, FL)

    Distance to nearest recruiting site
    ~48 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

    NCT07797335

    • Phase 3
    • Ages 45 years and older
    • Sex: All

    Nearest site: Clinical Research of Cent FL (Lakeland, FL)

    Distance to nearest recruiting site
    ~49 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Type 2 Diabetes clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.